The first study published?

Ann Oncol. 2015 Aug;26(8):1803. doi: 10.1093/annonc/mdv243. Epub 2015 May 21.

Authors

B P C van Oijen¹, F L G Erdkamp², H C Schouten³, P H M van der Kuy⁴

Affiliations

¹ Department of Clinical Pharmacy and Toxicology, Orbis Medical Center, Sittard br.vanoijen@orbisconcern.nl.
² Department of Haematology and Oncology, Orbis Medical Center, Sittard.
³ Department of Internal Medicine, University Hospital Maastricht, Maastricht, The Netherlands.
⁴ Department of Clinical Pharmacy and Toxicology, Orbis Medical Center, Sittard.

PMID: 25997817
DOI: 10.1093/annonc/mdv243

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents / adverse effects*
Female
Humans
Male
Medication Therapy Management*
Neoplasms / drug therapy*
Pharmacy Service, Hospital*
Polypharmacy*

Substances

Antineoplastic Agents